aod9604 stimulates lipolysis adipocytes Inside the Science of AOD 9604: A Peptide Sympathetic activation of adipocyte lipolysis

A 12-week cycle pairs with a 4-6 week break

Presentation: Lyophilized powder (research use) Target: Nicotinamide Nmethyltransferase (NNMT) inhibitor Suggested Use: In vitro / preclinical workflows as defined by protocol Storage: Follow validated lab SOPs for smallmolecule lyophilizates 1

Inspired by the Irish word Tura Beatha (pronounced Ba-ha) meaning journey of life our mission is to help you navigate the road ahead with confidence

Consult a healthcare provider if you experience: Persistent injection site reactions, signs of allergic reaction (rash, difficulty breathing, swelling), or any concerning symptoms that do not resolve quickly

AOD 9604 + NAD+ Combining AOD 9604 with NAD+ therapy at Perfect B in Doral targets two separate axes of metabolic function: NAD+ addresses cellular energy metabolism, mitochondrial efficiency, and metabolic resilience at the enzymatic level, while AOD 9604 drives fat mobilization from adipose tissue